Cite
HARVARD Citation
Samadder, N. et al. (n.d.). S1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis. American journal of gastroenterology. p. S614. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Samadder, N. et al. (n.d.). S1331 Phase II Trial of Weekly Erlotinib Dosing to Reduce Duodenal Polyp Burden Associated With Familial Adenomatous Polyposis. American journal of gastroenterology. p. S614. [Online].